# Fractal Optics Source: https://mesmerprism.com/projects/fractal-optics.html Canonical HTML: https://mesmerprism.com/projects/fractal-optics.html Generated: 2026-05-26 Description: Fractal Optics maps fractal phototherapy, retinal and ophthalmic stimulation, VR delivery, and patterned-light comparator literatures. Markdown: https://mesmerprism.com/projects/fractal-optics.md Plain text: https://mesmerprism.com/projects/fractal-optics.txt BibTeX references: https://mesmerprism.com/projects/fractal-optics.bib CSL JSON references: https://mesmerprism.com/projects/fractal-optics.references.csl.json --- Retinal stimulation and patterned light # Fractal Optics Fractal structure is treated here as stimulus, not vibe. Fractal phototherapy sits at a narrow junction of retinal stimulation, patterned light, VR delivery, and fractal physiology. The useful question asks what part of a stimulus is fractal, how it reaches the visual system, and what evidence exists for each claim. Here, fractal phototherapy means visual stimulation built from scale-free or fractal-patterned structure, especially in a small Russian ophthalmic and stereoscopic-display literature. [Back to work](https://mesmerprism.com/#work) [Brain Candy](https://mesmerprism.com/projects/brain-candy.html) [V1 form constants](https://mesmerprism.com/projects/bressloff-v1-form-constants.html) [References](https://mesmerprism.com/projects/fractal-optics.html#references) Evidence map ## What has to stay separate The account treats "fractal" as a measurable stimulus property rather than a vague synonym for complexity. The narrow problem is the Russian fractal phototherapy and stereoscopic-display line, plus the retinal, lighting, entrainment, and comparator literatures needed to understand what those claims might amount to. The core fractal-phototherapy literature is niche, so it needs independent comparison and replication context rather than the confidence of a settled intervention base. Nearby comparator material includes disease-specific reports on dry age-related macular degeneration and Stargardt disease, but those reports remain evidence to read carefully rather than a public treatment claim. As of May 20, 2026, the public record has a clearer shape: a broad brain-training patent, a narrower stereoscopic-display patent, 2024 methods and VR-rehabilitation papers, a 2025 software / clinical-trials report, and small disease-specific papers on dry AMD and Stargardt disease. That is enough for a careful map, with public efficacy still unproven. The evidence has to stay bounded. Spatial and temporal structure, ophthalmic and broader neurodynamic claims, and direct evidence and adjacent context such as biophilic fractal design, ipRGC lighting, or gamma entrainment all need to remain distinguishable. ### Current evidence map - Core fractal-phototherapy papers, patents, and clinical claims - Patent lineage from broad sensory-stimulation platform to ophthalmic stereoscopic-display method - Disease-specific visual-rehabilitation reports on dry AMD and Stargardt disease - Retinal and ophthalmic context for disease relevance and mechanism - Comparator stimulation families: 40 Hz, 60 Hz, heterochromatic flicker, and lighting-design work - Methods notes on fractal image analysis and temporal-stimulus generation ### Connected projects - [Brain Candy](https://mesmerprism.com/projects/brain-candy.html) for state-shift design and patterned-light translation - [Bressloff V1 Form Constants](https://mesmerprism.com/projects/bressloff-v1-form-constants.html) for geometric visual hallucination models - [Phenomenological Control](https://mesmerprism.com/projects/phenomenological-control.html) for induced-vision comparison and experience framing - [Optical Movement Illusions](https://mesmerprism.com/projects/optical-movement-illusions.html) for a different mechanism-first visual-perception archive Scope ## Usefulness Fractal Optics matters because it prevents a common collapse. It becomes easy to move too fast from fractal aesthetics, restoration, or broad brain metaphors to claims about retinal stimulation or visual rehabilitation. The useful reading is specifically about not making that jump without evidence. A careful account keeps modality, spatial structure, temporal structure, carrier frequency, and outcome domain separate. It also separates a broad patent/platform lineage from the narrower optical-device, stereoscopic-display, and disease-specific rehabilitation papers. The evidence map comes first; speculative design has to stay secondary. That separation matters most around VR. The current methods source describes portable and VR versions in which a homogeneous screen changes brightness according to a Weierstrass fractal function. The stereoscopic-display patent allows richer scene and overlay arrangements, but those scene options should not be treated as demonstrated therapeutic variables unless a direct study tests them. ### Public focus - Mechanism and evidence separation over aesthetic inflation - Comparator discipline across ophthalmic, lighting, and entrainment lines - Fractal claims tied to measurable structure, not decorative language Synthesis ## Fractal structure as stimulus, not vibe Fractal language is useful only when it stays tied to modality, measurement, and outcome. ### Fractal means structure Fractal Optics starts from a simple constraint: "fractal" should stay tied to structure rather than float as a synonym for organic, beautiful, recursive, healing, or complex. A fractal claim needs a structure that can be described, generated, measured, or compared. If a stimulus has spatial self-similarity, temporal modulation, lacunarity, box dimension, spectral slope, or a defined generation rule, then there is something to discuss. If it is merely an aesthetic resemblance, the claim stays aesthetic. The distinction matters because the subject sits near clinical and rehabilitation language. Retinal stimulation, fractal phototherapy, VR delivery, flicker, entrainment, lighting, and photobiomodulation can sound related in public summaries. Each belongs to a different evidence path. A spatial fractal image, a temporal flicker sequence, a wavelength-specific light treatment, and an immersive game scene may all use light, but they reach the visual system through different channels and carry different evidence burdens. ### The evidence line and the comparator line A workable reading keeps two lines separate. One line follows the Russian fractal phototherapy and ophthalmic rehabilitation literature as a specific intervention family, with attention to diagnosis, delivery mode, outcome measure, and source quality. The other line tracks comparators: flicker at different frequency bands, heterochromatic stimulation, melanopsin and ipRGC lighting pathways, photobiomodulation, spatial-fractal preference, restorative visual environments, and broader entrainment claims. Comparators help define where the fractal line begins and ends. They can suggest mechanisms worth checking, but they cannot substitute for direct evidence. A 40 Hz entrainment study, a blue-light circadian result, a photobiomodulation paper, and a fractal-fluency finding cannot automatically combine into one therapy. Fractal Optics has to resist that kind of easy synthesis. ### What the current sources say The public sources now have a defined spine. RU2671199C1 belongs to the broad sensory-stimulation and brain-training layer. RU2773684C1 is the narrower ophthalmic patent layer, built around fractal phototherapy with a stereoscopic head-mounted display. The 2024 methods paper describes portable and VR routes. The 2025 stereoscopic-display paper and the disease-specific reports add implementation and clinical-study records. The dry AMD report matters because it puts the method into a named retinal disease group and reports ERG changes after a two-week VR course. The Stargardt report matters because it extends the same line into a very small STGD1 sample and explicitly leaves larger confirmation work open. Those sources make the map more concrete, but they also make the caution sharper. ### What VR delivery would have to show VR makes the question more interesting and more difficult. A headset can control field of view, stereo depth, attention, timing, interaction, and compliance in ways a flat display cannot. It can also introduce confounds: optics, accommodation-vergence mismatch, motion discomfort, novelty, game framing, and adherence effects. In the current public source line, VR is best read first as a delivery, field-control, attention, and adherence surface. If it is also meant to be a therapeutic variable, the delivery method has to be part of the claim rather than a decorative carrier. A strong VR claim would specify what is fractal, what is temporal, what is spatial, what part of the retina or visual pathway is being targeted, what the user is doing, what the comparison condition is, and what outcome changed. A weak claim would only say that immersive fractals are therapeutic. The first route should stay open; the second should stay out. ### Why the evidence stays cautious Fractal Optics still lacks enough evidence for a treatment claim. The useful work is separation: each source has to be read by modality, structure, carrier, frequency, outcome, and evidence type. That sounds modest, but it is the difference between a usable research map and a persuasive collage. The cautious stance also keeps the line compatible with design work. Fractal stimuli may still be useful for attention, comfort, perceptual fluency, fascination, or experimental probing even where therapeutic claims remain unproven. The point is to say which claim is being made each time. References ## Current references These sources define the Fractal Optics line. The first group documents the fractal-phototherapy, patent, and retinal thread; the second provides comparator mechanisms and methods. ### Core fractal-phototherapy and retinal line - Zueva et al. "[Fractal Phototherapy in Neuroprotection of Glaucoma](https://doaj.org/article/9949b294f47e4d80b8ff4b298e609ceb)." Ophthalmology in Russia (2019). - Neroev et al. "[RU2671199C1: Method of Brain Training](https://patents.google.com/patent/RU2671199C1/ru)." Patent record (2018). - Neroev et al. "[RU2773684C1: Method for Improving the Functional Activity of the Visual System Using Fractal Phototherapy with a Stereoscopic Display](https://findpatent.ru/patent/277/2773684.html)." Patent record (2022). - Neroev et al. "[Changes in Functional Activity of Rabbit’s Retina During Flicker Photostimulation with Scale-free Dynamics](https://doi.org/10.35745/ijcmb2022v02.02.0001)." International Journal of Clinical and Medical Biology (2022). - Zueva et al. "[Editorial: Fractals in the Diagnosis and Treatment of the Retina and Brain Diseases](https://doi.org/10.3389/fnetp.2022.1054439)." Frontiers in Network Physiology (2022). - Zueva et al. "[Fractal Phototherapy in Maximizing Retina and Brain Plasticity](https://doi.org/10.1007/978-3-031-47606-8_31)." In The Fractal Geometry of the Brain (2024). - Zueva et al. "[Virtual Reality in Visual Rehabilitation](https://doi.org/10.21516/2072-0076-2024-17-3-113-118)." Russian Ophthalmological Journal (2024). - Zueva et al. "[Methods of Fractal Phototherapy in Visual Rehabilitation of Patients with Age-Associated Retinal Diseases](https://doi.org/10.25276/2312-4911-2024-4-301)." Conference / source page (2024). - Zueva et al. "[Main Results of Human Clinical Trials of the Stereoscopic Display Software](https://umedp.ru/upload/iblock/dd6/effektivnaya_farmakoterapiya_oftalmologiya_3_2025.pdf)." Effective Pharmacotherapy. Ophthalmology (2025). - Neroeva et al. "[Influence of Fractal Photostimulation on Electroretinogram in Patients with Dry Age-Related Macular Degeneration](https://doi.org/10.21516/2072-0076-2025-18-2-80-89)." Russian Ophthalmological Journal (2025). - Kotelin et al. "[Fractal Phototherapy in Visual Rehabilitation of Patients with Stargardt Disease](https://doi.org/10.21516/2072-0076-2025-18-4-74-82)." Russian Ophthalmological Journal (2025). ### Comparators, theory, and methods - Taylor et al. "[Fractal Fluency: Processing of Fractal Stimuli Across Sight, Sound, and Touch](https://doi.org/10.1007/978-3-031-47606-8_45)." In The Fractal Geometry of the Brain (2024). - Valter et al. "[Photobiomodulation Use in Ophthalmology: An Overview of Translational Research from Bench to Bedside](https://doi.org/10.3389/fopht.2024.1388602)." Frontiers in Ophthalmology (2024). - Karperien et al. "[Box-Counting Fractal Analysis: A Primer for the Clinician](https://doi.org/10.1007/978-3-031-47606-8_2)." In The Fractal Geometry of the Brain (2024). - Hewitt et al. "[Stroboscopically Induced Visual Hallucinations: Historical, Phenomenological, and Neurobiological Perspectives](https://doi.org/10.1093/nc/niaf020)." Neuroscience of Consciousness (2025). - Amaya, Nierhaus, and Schmidt. "[Thalamocortical Interactions Reflecting the Intensity of Flicker Light-Induced Visual Hallucinatory Phenomena](https://doi.org/10.1162/netn_a_00417)." Network Neuroscience (2025). - Alamalhoda et al. "[Exploring Neural Entrainment and Altered States of Consciousness Through Repeated 60 Hz Flickering White Light Stimulation](https://doi.org/10.1371/journal.pone.0332310)." PLOS ONE (2025).